Additional sector guidance – Biotechnology and pharmaceuticals
Detalles
This document provides additional guidance in the pharmaceutical and biotechnology sector. This covers: The assessment of nature-related issues using the TNFD's LEAP approach and the disclosure of sector-specific metrics in line with the approach recommended by the TNFD.
Recursos relacionados
Making Biodiversity Material in Financial Decision-Making
Until recently, financial and commercial actors could ignore the impact of their activities on ecosystems. They were considered an externality…
AECOM TNFD Pilot: Nature risk screening for multiple infrastructure projects across Asia
The TNFD has developed a series of recommendations and guidelines for organizations to identify, assess, manage and, where appropriate, disclose…
Critical Minerals at a Critical Moment
The report presents a comprehensive analysis of the spatial overlap between critical mineral extraction sites and key biodiversity areas.